Skip to main content

Henry Schein Value Stock - Dividend - Research Selection

Henry schein

ISIN: US8064071025 , WKN: 897961

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

We believe we are the world’s largest provider of health care products and services primarily to office-based dental, animal health and medical practitioners.  We serve more than 1 million customers worldwide including dental practitioners and laboratories, animal health clinics and physician practices, as well as government, institutional health care clinics and other alternate care clinics.  We believe that we have a strong brand identity due to our more than 84 years of experience distributing health care products.

 

We are headquartered in Melville, New York, employ more than 21,000 people (of which more than 10,500 are based outside the United States) and have operations or affiliates in 33 countries, including the United States, Australia, Austria, Belgium, Brazil, Canada, Chile, China, the Czech Republic, Denmark, France, Germany, Hong Kong SAR, Iceland, Ireland, Israel, Italy, Japan, Luxembourg, Malaysia, the Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Slovakia, South Africa, Spain, Sweden, Switzerland, Thailand and the United Kingdom.

 

We offer a comprehensive selection of products and services and value-added solutions for operating efficient practices and delivering high quality care.  We operate through a centralized and automated distribution network with a selection of more than 120,000 branded products and Henry Schein private brand products in stock, as well as more than 180,000 additional products available as special order items.  We also offer our customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services.

 

We have established over 4.5 million square feet of space in 62 strategically located distribution centers around the world to enable us to better serve our customers and increase our operating efficiency.  This infrastructure, together with broad product and service offerings at competitive prices, and a strong commitment to customer service, enables us to be a single source of supply for our customers’ needs.  Our infrastructure also allows us to provide convenient ordering and rapid, accurate and complete order fulfillment.

 

We conduct our business through two reportable segments: (i) health care distribution and (ii) technology and value-added services.  These segments offer different products and services to the same customer base. 

 

The health care distribution reportable segment aggregates our global dental, animal health and medical operating segments.  This segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.  Our global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions.  Our global animal health group serves animal health practices and clinics.  Our global medical group serves office-based medical practitioners, ambulatory surgery centers, other alternate-care settings and other institutions. 

 

Our technology and value-added services group provides software, technology and other value-added services to health care practitioners.  Our technology group offerings include practice management software systems for dental and medical practitioners and animal health clinics.  Our value-added practice solutions include financial services on a non-recourse basis, e-services, practice technology, network and hardware services, as well as continuing education services for practitioners.

 

Source: www.sec.gov

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


How Is Henry Schein's Stock Performance Compared to Other Healthcare Stocks?

2025-12-18
Despite Henry Schein’s underperformance relative to its peers, Wall Street analysts remain moderately optimistic about the stock’s prospects.

3 Small-Cap Stocks We Steer Clear Of

2025-12-12
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.

How Henry Schein’s (HSIC) Expanded Curodont Deal Could Reshape Its Technology-Enabled Margin Story

2025-12-10
Earlier this month, Henry Schein, Inc. announced an expanded agreement with Swiss firm vVARDIS, granting it exclusive U.S. distribution rights for the drill-free Curodont Repair Fluoride Plus cavity treatment across all dental market segments from January 1, 2026. This move deepens Henry Schein’s role in minimally invasive dental care by turning an underserved pool of early-stage cavity patients into a new treatment and revenue channel for practices. We’ll now examine how broader Curodont...

Why Henry Schein (HSIC) Stock Is Up Today

2025-12-09
Shares of dental and medical products company Henry Schein (NASDAQ:HSIC) jumped 2.8% in the afternoon session after Barclays initiated coverage on the company with an 'Overweight' rating and an $86 price target. The rating from the bank reflected a positive outlook on the company's potential for growth. Analyst Glen Santangelo announced the new coverage. Adding to the positive sentiment, Henry Schein also announced an extension of its strategic partnership with KKR. As part of the agreement, KKR

Henry Schein, Inc. (HSIC): A Bull Case Theory

2025-12-09
We came across a bullish thesis on Henry Schein, Inc. on X.com by FullySynergized. In this article, we will summarize the bulls’ thesis on HSIC. Henry Schein, Inc.’s share was trading at $73.11 as of December 1st. HSIC’s trailing and forward P/E were 23.06 and 13.95 respectively according to Yahoo Finance. Henry Schein, Inc. (HSIC) is the largest […]

Henry Schein Can Make Your Portfolio Smile

2025-12-05
Henry Schein, Inc. is rated a Buy with solid growth, strong Q3 revenue & improved profitability across all segments. Learn more about HSIC stock here.

Why Is Henry Schein (HSIC) Up 1.2% Since Last Earnings Report?

2025-12-04
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Q3 Rundown: Henry Schein (NASDAQ:HSIC) Vs Other Dental Equipment & Technology Stocks

2025-12-04
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the dental equipment & technology stocks, including Henry Schein (NASDAQ:HSIC) and its peers.

HSIC Stock Benefits From Expanded Partnership With vVARDIS

2025-12-02
Henry Schein gains exclusive U.S. rights to Curodont, expanding its vVARDIS partnership and boosting expectations for a Dental business rebound.

Henry Schein, Inc. (HSIC) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

2025-12-02
Henry Schein, Inc. (HSIC) Piper Sandler 37th Annual Healthcare Conference December 2, 2025 9:00 AM ESTCompany ParticipantsStanley Bergman - Executive...